BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 03/31/2016

Position Statistics

Total Positions 84
New Positions 3
Increased Positions 13
Decreased Positions 40
Positions with Activity 53
Sold Out Positions 18
Total Mkt Value (in $ millions) 858

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 1.42%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 79.22%
Services
Technology
Transportation
Utilities

18 Sold Out Positions as of 03/31/2016

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held ▲
AMAG PHARMACEUTICALS INC COM -5,652 Sold Out 0
AMPHASTAR PHARMACEUTICALS INC COM -15,466 Sold Out 0
AMPLIPHI BIOSCIENCES CORP COM NEW -900 Sold Out 0
ATRICURE INC COM -11,490 Sold Out 0
BIODEL INC COM NEW -778 Sold Out 0
BIOLINERX LTD SPONSORED ADR -3,185 Sold Out 0
CARBYLAN THERAPEUTICS INC COM -1,179 Sold Out 0
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR -6,968 Sold Out 0
DEPOMED INC COM -14,374 Sold Out 0
EMERGENT BIOSOLUTIONS INC COM -28,189 Sold Out 0
FATE THERAPEUTICS INC COM -1,749 Sold Out 0
GENOCEA BIOSCIENCES INC COM -3,351 Sold Out 0
ORASURE TECHNOLOGIES INC COM -4,778 Sold Out 0
PALATIN TECHNOLOGIES INC COM PAR $ .01 -725 Sold Out 0
RIGEL PHARMACEUTICALS INC COM NEW -7,688 Sold Out 0
ST JUDE MED INC COM -15,260 Sold Out 0
TITAN PHARMACEUTICALS INC DEL COM NEW -5,222 Sold Out 0
VALEANT PHARMACEUTICALS INTL I COM -23,589 Sold Out 0